CHEK1 and lymphoma: Results from our Eμ-Myc lymphoma cell proteomic analysis above, together with the loss of CHK1 protein but not mRNA in the CCT244747 resistant U2OS cells, suggested that post-transcriptional regulation of protein levels was a key factor in acquisition of both de novo and acquired CHK1 inhibitor resistance.